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Introduction
Drug-related morbidity and mortality is an epidemic
patient safety problem, estimated to result in $76 billion
dollars in total costs annually.1 One drug-related
problem, adverse drug events (ADEs), broadly deﬁned
as injuries due to medications,2 is estimated to occur
in 25%of ambulatory patients. Approximately 11%of
ADEs are considered preventable and an additional
28%are ameliorable (i.e. their severity or duration could
be decreased if proper action were taken).3 Equally
problematic is undertreatment of chronic diseases,
where patients are estimated to receive approximately
half of all recommended care.4
The causes of ambulatory ADEs and undertreatment
often stem from one of three problems: medication
discrepancies,non-adherenceand inadequatemonitoring
and follow-up (e.g. regarding discrepancies, non-adher-
ence or the development of symptoms that could be
ADEs). Medication discrepancies are unexplained
diﬀerences between the medication regimen a patient
thinks he should be taking and the regimen collectively
prescribed by his physicians, or between documented
regimens across diﬀerent sites of care.5 For example, a
patient might think he is supposed to take both atenolol
100 mg po qd as well as metoprolol XL 200 mg po qd
because he did not understand (or was never explicitly
told) that one medication had been substituted for the
other during a previous hospitalisation. Discrepancies
can have serious consequences, including prolonged
periods of overtreatment or undertreatment. Of the 350
medication errors resulting in serious injury in the Joint
Commission’s sentinel event database, approximately
30% could be attributed to unintentional medication
discrepancies.6 Causes of discrepancies include lack of
communication among multiple outpatient providers,
the lack of one provider responsible for maintaining a
complete and accurate medication list (even within an
electronic health record (EHR)),7,8 inadequate health
literacy among patients9 and changes in medications,
discontinuity of care and inadequate patient edu-
cation during transitions in care.10–13
Medication non-adherence, or diﬀerences between
the regimen a patient thinks he should be taking and
what he is actually taking, is estimated to occur in
approximately 50–75% of patients.14–16 (Note that this
deﬁnition of adherence is diﬀerent than the one used
by Osterberg and colleagues, ‘the extent to which
patients takemedications as prescribed by their health
care providers’.15 This latter deﬁnition does not
distinguish between medication discrepancies and
non-adherence, a distinction that is crucial to any
intervention designed to improve the accuracy of a
medication list in an EHR shared by patients and
providers.) Inone large survey, 30%of patients admitted
to taking prescription medications less often than
prescribed, 26% delayed ﬁlling a prescription, 21%
stopped taking a prescription sooner than prescribed,
18% never ﬁlled a prescription and 14% took smaller
doses thanprescribed.17Medication non-adherence can
lead to poor control of chronic diseases such as hyper-
cholesterolemia, diabetes, hypertension and heart fail-
ure.16,18–20 Causes of non-adherence include the high
cost of medications, the inconvenience of taking daily
medications and obtaining reﬁlls, and lack of appreci-
ation for medication indications, especially for asymp-
tomatic conditions such as hypertension.
Inadequate monitoring for medication discrep-
ancies, non-adherence, or the development of ADEs
is also extremely common. (A full discussion of moni-
toring, such as therapeutic drug monitoring (e.g. INR
levels for patients prescribed warfarin) is beyond the
scope of this article because the PG medication module
does not address this issue in any direct way.) Medi-
cation discrepancies, by deﬁnition, will not be reported
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module on important medication-related outcomes
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prove on this approach.
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by patients and can only be detected by active surveil-
lance. Regarding ADEs, patients often are unaware that
symptoms they are experiencing are due to medi-
cations. Even if they do suspect a medication eﬀect,
patients may not report it to their physicians and
physicians may not actively solicit this information.3,21
Thus, physicians cannot take action to ameliorate the
severity or duration of symptoms. Medication non-
adherence is also underreported, and physicians do
not actively solicit this information.22 Communication
regarding drug-related problems may be completely
absent between patient visits, but is often inadequate
even during visits because of time constraints, clinical
inertia, patient concerns about ‘bothering’ their phys-
icians, and/or lack of patient involvement in their own
care. As a result, ADEs and undertreatment remain
undetected and the opportunity to prevent or ameli-
orate these problems is lost.
By empowering patients to become active partici-
pants in their own care, an interactive patient portal
linked to an EHR has the potential to help address
many medication safety and quality issues.23 If designed
properly, a patient portal module focused on medi-
cation safety would allow patients online access to the
medication and allergy data from their ambulatory
EHR, allow them to interact with the data and update
it as necessary, identify discrepancies, report ADEs
and non-adherence, then convey this information
back to the patient’s physician, who can discuss the
information with the patient, update the EHR, docu-
ment drug-related problems and take action as needed.
At Partners HealthCare (Massachusetts, USA), we
have developed and deployed such a tool within
Patient Gateway (PG), our patient portal, to address
these medication issues as part of the Prepare for Care
study.24,25 We hypothesised that the PG Medications
Module would facilitate patient–provider communi-
cation, increase the detection and handling of discrep-
ancies and ADEs, improve the documentation of
medications and allergies within the Partners EHR,
increase patient knowledge of and adherence with
their medications and increase patients’ satisfaction
with care. The purpose of this manuscript is to
describe the PG Medications Module, including the
design and experience of the application from the
patient’s and provider’s viewpoint, preliminary usage
data, the evaluation plan and lessons learned to date.
Study setting
Partners HealthCare was formed in 1994 by
Massachusetts General Hospital and Brigham and
Women’s Hospital. Since its inception, this integrated
delivery network has grown to include ﬁve acute care
hospitals, four rehabilitation and long-term care facil-
ities and a large network of primary care and specialty
physicians. Clinical activities in the ambulatory setting
are supported by the enterprise EHR – the Longitudinal
Medical Record (LMR),which currently has over 7000
clinical users.
Patient Gateway
As part of a system-wide strategy to facilitate com-
munication between patients and their physicians,
PartnersHealthCare began in 2000 to develop a secure
patient portal PG. PG allows patients to update their
contact information, renew their medication pre-
scriptions, request appointments and referrals, com-
municate with their practice via secure web mail and
access a licensed health information library.26 As
of July 2007, PG supported 35 680 patients (23 296
accounts used) across 30 primary care and specialty
practices, with more than 4200 unique patients using
it in any given month. The functionality described in
the remainder of this manuscript was developed by
adding further features to the base PG product for use
in the Prepare for Care study.
Design of the PG Medications Module
Aswith other components of Prepare for Care,24,27 the
Medications Module was designed so that patients
could use it prior to a scheduled primary care phys-
ician (PCP) visit. During these sessions, patients can
view information from the LMR, interact with it and
create ‘journals’ that can then be sent to their PCPs.
PCPs or their representatives can then view the con-
tents of a journal, discuss it with the patient to verify
the information and explore any underlying issues,
use the journal to facilitate entry of information into
the LMR and take other action as necessary.
User interface design process
A multidisciplinary team consisting of physicians,
medication safety experts, information technology
analysts, programmers and clinical researchers was
assembled to develop the functional requirements for
the Medications Module. The team then iteratively
developed a series of paper-based and then electronic
prototypes to reﬁne the details of the design. We also
solicited input from an advisory council comprised of
primary care physicians from practices already using
the basic PG product. Finally, we conducted a series of
usability tests with volunteer patients going through
mock scenarios to enhance the ease of navigation and
clarity of the user experience.
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Patient view
The patient interaction with the Medications Module
systematically leads the patient from issues of medi-
cation accuracy to those of adherence and ADEs. First,
the patient sees the current active medication list as it
exists in the LMR. The Medications Module then asks
the patient to compare this list with the list of medi-
cations the patient thinks he or she should be taking.
The patient is then asked details regarding any dis-
crepancies (diﬀerences in dose or frequency, additional
medications, or missing medications; see Figure 1).
Patients are then speciﬁcally asked in a non-
judgementalway about anyproblems theymaybehaving
with adherence. If problems exist, the reasons for non-
adherence are explored using a menu of potential
choices, such as cost, diﬃculty getting reﬁlls, or for-
getting to take a medication regularly. Patients are then
asked whether they are having possible side eﬀects. If
yes, the type, duration and conﬁdence in the symptom
being related to that medication are elicited, followed
by whether the PCP is aware of the side eﬀect. Lastly,
the system asks whether the patient knows the indi-
cations for each medication, whether they think it’s
helping and if they need a prescription reﬁll (see
Figure 2). At any time, the patient can go directly to
licensed health information (from Healthwise, Inc.,
Boise, ID) regarding any medication on their list.
Several key design decisionsweremadewhen creating
the Medications Module. First, we had to balance the
need for structured and coded information (which can
drivedecision support and facilitate entryof information
by the PCP into the LMR)with the convenience of free
text entry (which is easier and faster for patients,
especially if they are not familiar withmedication names
or terminology such as dose, strength and frequency).
In the end, we decided to have structured (but not
coded) information for most ﬁelds, with examples of
how to enter the information, but allowed for free text
when asking about additional medications in order to
avoid patient confusion.
Second, throughout the system, we used patient-
friendly language, drop-down menus and branching
logic to make the system as fast and easy to use as
possible. Finally, as mentioned above, we purposely
addressed issues of discrepancies before addressing
those of adherence or ADEs, since the latter two only
apply to medications the patient thinks he or she
should be taking.
Physician view
For PCPs, the major requirements were that the
Medications Module ﬁt into their workﬂow, present
a concise overview of the information and facilitate
eﬃcient veriﬁcation and documentation of information
within the LMR. To that end, a visit-basedmedication
journal only goes to the patient’s assigned PCP (as
designated by the patient at the time of PG enrolment)
before visits that have been scheduled at least three
weeks in advance (i.e. non-urgent visits) or are desig-
nated as an annual visit. If a patient has submitted a
medication journal, then the clinician view of the
Figure 1 Veriﬁcation of medication regimen accuracy
Figure 2 Identiﬁcation of non-adherence and adverse drug events
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patient’s medication journal is displayed in the LMR
in the place of the usual medications screen. This screen
displays the usual medication information along with
the information submitted by the patient (Figure 3),
including medication discrepancies and reports of
non-adherence, side eﬀects or lack of understanding
of medication indications. With a few mouse clicks, a
PCP can move veriﬁed journal information into the
LMR (e.g. delete a medication a patient is no longer
taking and is no longer needed or tolerated, or change
a dose). Additional medications taken by the patient
can also be added; if the free text medication name
supplied by the patient is recognised by the LMR
medication dictionary, this process can be facilitated.
As with the patient view, several key design deci-
sions were made when creating the physician view.
First was the decision to essentially replace the usual
LMR medications screen with the medication journal
for applicable visits. Because the LMR incorporates
electronic medication prescribing, PCPs almost always
access the medications screen during a patient visit.
Thus, this decision virtually guaranteed that physicians
would interact with a submitted medication journal.
Journal entries are no longer displayed on the medi-
cations screen once the journal is closed or expired.
Second, the system supports provider veriﬁcation
of patient journal information. It is very easy to delete
medications from the LMR list in response to a patient
journal, with a single click. Modifying or adding patient
journal information to the LMR requires more steps,
since patient journal entriesmight contain uncodedor
unstructured information, and providers need to decide
how the LMR should be updated. For modiﬁcations, a
user must click on the medication name to go to the
electronic prescription pad, where they see the patient’s
journal comments but have to enter the changes
themselves. We felt that this struck the best balance
between ease of use and patient safety (e.g. we did not
want to make it too easy for unconﬁrmed medication
information to be moved directly into the LMR).
Allergies
TheMedicationModule also allows for veriﬁcation of
allergy information in amanner completely analogous
to the process for medications. Patients interact with
their coded allergy information from the LMR (includ-
ingdrugs, foods andother allergens, aswell as reactions to
each), and can verify or update the information as
needed and submit it along with their medications
journal. PCPs or nurses can then communicate with
patients, verify any new information and update the
LMR allergy section with just a few clicks.
Deployment strategy
We relied on several approaches to deploy the Medi-
cations Module within the PG product platform as
part of the Prepare for Care study. First, we identiﬁed
physician champions in each practice and solicited
their input for optimal ways to deploy theMedications
Module within their practice. Second, we presented
the Medications Module to physicians at practice
meetings to introduce its functionality to the clin-
icians. Third, we provided onsite and online support
and returned to practices to hear feedback about the
Figure 3 Clinician view of LMR med screen with added journal meds
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Medications Module after rollout. Fourth, we pro-
vided marketing materials to practices so that patients
became aware of this new feature. Fifth, we sent
reminders through the base PG product to all patients
who had consented to the study to prompt them to
review and update their medication and allergy infor-
mation in theMedicationsModule prior to an eligible
upcoming visit.
Short-term evaluation plan
The Medications Module was implemented between
September 2005 and March 2007 at four primary care
practices within our integrated delivery network, in
conjunction with a diabetes module.24 Patients with
an active PG account were invited to participate in the
study. Enrolled patients with a forthcoming scheduled
visit with their primary care physician were invited
to complete a medication journal and therefore were
eligible to participate in this part of the evaluation.
To evaluate the usage of the Medications Module by
patients and clinicians, we recorded the following:
i) the number of consented and eligible patients who
accessed the Medications Module to review their
medications and allergies; ii) the number of patients
who submitted their information in the form of a
medication journal and iii) the proportion of patient-
submitted journals that were electronically reviewed
by providers.
To evaluate patient attitudes towards the use of the
medicationmodule, patients were invited to complete
a short online survey three days after a scheduled visit
for which a journal had been opened. On this survey,
patients were asked to rate on Likert scales their
experience in reviewing and updating their medical
records online, including whether they found the
medications module easy to use, whether they felt
more prepared for the visit and whether the use of the
module led their providers to have more accurate
clinical information.
Short-term evaluation results
Table 1 presents the characteristics of all the patients in
the primary care practices that used PG during the
study period (in both arms of the Prepare for Care
study), those patients with an active PG account invited
to participate in the study, those who gave informed
consent to participate and those who completed a
visit-based journal.Moving from the ﬁrst to the fourth
group of patients, there is a trend for patients to be
older, to be white, to live in less impoverished zip
codes and to have more frequent physician visits per
year.
During the study period, 12 278 patients with active
PG accounts who sought primary care at one of the
four Medications Module intervention practices were
invited to participate in the study. Of them, 2273
(19%) completed the consent process. Of these, 1457
Table 1 Characteristics of patients in Prepare for Care primary care practices
All patients in
practices that
use Patient
Gateway
Patients with
active Patient
Gateway
accounts invited
to participate in
study
Invited patients
consented and
enrolled in
study
Study patients
who submitted
a visit-based
journal
Number of patients 126 552 28 757 5298 1893
Mean age, y 46 45 48 51
Female, % 63 64 59 61
White race, % 68 80 83 85
Median income by zip code
below federal poverty line, %
10.3 9.3 9.2 8.9
Mean annual number of visits
to PCP 2.6 2.6 3.5 4.1
to other providers 6.0 6.1 7.8 8.1
Mean number of ways patients
report using the internet
3.7 4.2
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(64%) patients had a forthcoming scheduled primary
care visit and were invited to complete a visit-based
medication journal at least three weeks prior to the
visit. Of these, 1131 patients (78%) opened a medi-
cations journal and 1053 (72%) completed the review
and updating process and submitted a journal for
review. Data were reviewed electronically within the
LMR for 812 (77%) of these patients.
In addition, 687 consented patients who opened
their invitation to complete a medication journal
prior to a visit were further invited to complete a brief
survey of their journal experience three days after their
visit. Of these patients, 466 (68%) responded (Table 2).
Overall, 70% of these patients found the journal very
easy or easy to complete. Fifty-three percent either
strongly agreed or agreed that the use of the journal led
their providers to have more accurate information
about them, while 39% felt neutral about the journal’s
impact in this area. Similarly, 56% of respondents
strongly agreed or agreed that they felt more prepared
for their visit with the use of the journal, while 35%
reported that they felt neutral about the journal’s
impact on feelings of preparedness.
Discussion
Our preliminary ﬁndings demonstrate that a patient
portal-linked tool designed to help improve medication
safety has promise, at least for those who use it. Of the
patients who chose to take part in the study and were
asked to complete amedications journal, approximately
72% submitted a journal for review and about 77% of
these were reviewed by physicians during the subse-
quent visit. Patient survey data showed that themajority
of patients who used a medication journal found it
easy to use, and felt that it led to their providers having
more accurate information about them and enabled
them to feelmore prepared for their forthcoming visit.
However, only about 20% of eligible patients consented
to be in the study in the ﬁrst place, and these eligible
patients made up less than a quarter of all patients in
these practices, since most patients had never signed
up to use PG. This lack of reach both limits the gen-
eralisability of our researchﬁndings and also represents a
major barrier to be overcome if interventions such as
these are to have eﬀects on a broader patient popu-
lation. That PG andMedicationsModule users tended
to be white and less impoverished than non-users is
particularly worrisome and it will likely require major
outreach eﬀorts to bridge the so-called ‘digital divide’.
The development of the Medications Module illus-
trates several important lessons for others engaged in
developing these kinds of applications:
. the critical importance of amultidisciplinary design
team and iterative reﬁnement of the application
. the need for usability testing at several points during
the development cycle, including with patients
. the use of a judiciousmix of free text, structured and
coded data ﬁelds within the patient interface to
optimise the usefulness of patient-entered data with-
out confusing or overwhelming patients
. the need to give clinicians the ability to verify and
correct patient-entered data while still facilitating
entry of that data into the EHR
. the importance of integrating the clinician side of
the application with clinicians’ workﬂow to maxi-
mise use and usability
. the need to document both medication and allergy
information within one application to avoid poten-
tial drug–allergy interactions.
Table 2 Patient satisfaction survey results
With use of journal Patient response, % (n=466)
Strongly
agree
Agree Neutral Disagree Strongly
disagree
My provider had more accurate info
about me
17 35.5 38.6 7 1.8
I felt more prepared for my visit 18.3 37.4 35.1 7.2 1.9
Very easy Easy Neither Diﬃcult Very
diﬃcult
Patient experience of completing journal
online
27.9 41.9 20.4 2.3 0.4
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Long-term evaluation plan
We are currently studying the impact of the PG
Medications Module on patient outcomes with a
cluster randomised controlled trial (clinicaltrials.gov
#NCT00251875). As part of thePrepare for Care study,
we designed four new PG modules: medications/
allergies, diabetes, health maintenance and family
history. We randomised Partners primary care prac-
tices with PG to receive two of the four modules
(medications and diabetes in one study arm versus
health maintenance and family history in the other).
In this way, patients who submitted a journal about
medications/allergies could be compared to patients
who submitted a journal unrelated to medications.
Clinical outcomes to be evaluated include ameliorable
and preventable ADEs, LMR medication list accuracy
(i.e. unexplained discrepancies), self-reported medi-
cation adherence and patient-reported communication
with PCPs regarding ADEs.
Conclusions
The PGMedicationsModule represents amajor eﬀort
to engage the patient directly in medication surveil-
lance in order to decrease seriousmedication errors in
the outpatient setting. We believe that integration of
this kind of intervention into a patient portal repre-
sents a novel and potentially powerful way to reduce
ADEs andmedication discrepancies. The eﬀects of this
intervention on a variety of outcomes are currently
being tested. Expanding its use to a broader popu-
lation will be a major focus going forward. Ongoing
education of both physicians and patients regarding
the prevalence and seriousness of medication discrep-
ancies and ADEs and the importance of communi-
cation about these issues will also be needed to produce
the culture change necessary to improve medication
safety.
REFERENCES
1 Johnson JA and Bootman JL. Drug-related morbidity
and mortality: a cost-of-illness model. Archives of Internal
Medicine 1995;155:1949–56.
2 Bates DW, Cullen DJ, Laird N et al. Incidence of adverse
drug events and potential adverse drug events: impli-
cations for prevention. ADE Prevention Study Group.
Journal of the American Medical Association 1995;274:
29–34.
3 Gandhi TK, Weingart SN, Borus J et al. Adverse drug
events in ambulatory care. New England Journal of
Medicine 2003;348:1556–64.
4 McGlynn EA, Asch SM, Adams J et al. The quality of
health care delivered to adults in the United States.New
England Journal of Medicine 2003;348:2635–45.
5 Schnipper JL, Kirwin JL, Cotugno MC et al. Role of
pharmacist counseling in preventing adverse drug
events after hospitalization.Archives of InternalMedicine
2006;166:565–71.
6 Using medication reconciliation to prevent errors. Joint
Commission Journal of Quality and Patient Safety 2006;
32:230–2.
7 Kaboli PJ, McClimon BJ, Hoth AB and Barnett MJ.
Assessing the accuracy of computerized medication
histories. American Journal of Managed Care 2004;10:
872–7.
8 Staroselsky M, Volk LA, Tsurikova R et al. An eﬀort to
improve electronic health record medication list accu-
racy between visits: patients’ and physicians’ response.
International Journal of Medical Informatics 2008;77(3):
153–60.
9 Kripalani S,Henderson LE, Chiu EY,RobertsonR,Kolm
P and Jacobson TA. Predictors of medication self-
management skill in a low-literacy population. Journal
of General Internal Medicine 2006;21:852–6.
10 Alibhai SM, Han RK and Naglie G. Medication edu-
cation of acutely hospitalized older patients. Journal of
General Internal Medicine 1999;14:610–16.
11 Beers MH, Dang J, Hasegawa J and Tamai IY. Inﬂuence
of hospitalization on drug therapy in the elderly. Journal
of the American Geriatric Society 1989;37:679–83.
12 Kripalani S, Phillips CO, Basaviah P,WilliamsMV, Saint
SK and Baker DW.Deﬁcits in information transfer from
inpatient to outpatient physician at hospital discharge: a
systematic review. Journal of General Internal Medicine
2004;19(S1):135.
13 Calkins DR, Davis RB, Reiley P et al. Patient–physician
communication at hospital discharge and patients’ under-
standing of the postdischarge treatment plan.Archives of
Internal Medicine 1997;157:1026–30.
14 DiMatteo MR. Variations in patients’ adherence to
medical recommendations: a quantitative review of 50
years of research. Medical Care 2004;42:200–9.
15 Osterberg L and Blaschke T. Adherence to medication.
New England Journal of Medicine 2005;353:487–97.
16 Vermeire E, Hearnshaw H, Van Royen P and Denekens
J. Patient adherence to treatment: three decades of
research – a comprehensive review. Journal of Clinical
Pharmacy and Therapeutics 2001;26:331–42.
17 Boston Consulting Group. The Hdden Epidemic: ﬁnding
a cure for unﬁlled prescriptions and missed doses. Boston
Consulting Group; December 2003.
18 Insull W. The problem of compliance to cholesterol
altering therapy. Journal of Internal Medicine 1997;241:
317–25.
19 McDermott MM, Schmitt B and Wallner E. Impact of
medication nonadherence on coronary heart disease
outcomes: a critical review [see comments]. Archives of
Internal Medicine 1997;157:1921–9.
20 World Health Organization. Adherence to Long-term
Therapies: evidence for action. Geneva, 2003.
21 Grant RW, Devita NG, Singer DE and Meigs JB.
Polypharmacy and medication adherence in patients
with type 2 diabetes. Diabetes Care 2003;26:1408–12.
Design and implementation of a web-based patient portal linked to an EHR 155
22 Bokhour BG, Berlowitz DR, Long JA and Kressin NR.
How do providers assess antihypertensive medication
adherence in medical encounters? Journal of General
Internal Medicine 2006;21:577–83.
23 Tang PC,Ash JS, BatesDW,Overhage JMand SandsDZ.
Personal health records: deﬁnitions, beneﬁts, and strat-
egies for overcoming barriers to adoption. Journal of the
American Medical Informatics Association 2006;13:121–6.
24 Grant RW, Wald JS, Poon EG et al. Design and im-
plementation of a web-based patient portal linked to an
ambulatory care electronic health record: patient gate-
way for diabetes collaborative care. Diabetes Technology
and Therapeutics 2006;8:576–86.
25 Wald JS, Bates DW and Middleton B. A patient-con-
trolled journal for an electronic medical record: issues
and challenges. Medinfo 2004:1166–72.
26 Poon EG, Wald J, Bates DW, Middleton B, Kuperman
GJ and Gandhi TK. Supporting patient care beyond the
clinical encounter: three informatics innovations from
Partners Health Care. Proceedings of the AmericanMedi-
cal Informatics Association Symposium 2003:1072.
27 Poon EG, Wald J, Schnipper JL et al. Empowering
patients to improve the quality of their care: design and
implementation of a shared health maintenance module
within a US integrated healthcare delivery network. Paper
presented at the MedInfo World Congress on Health
Informatics, 2007.
CONFLICTS OF INTEREST
None.
ADDRESS FOR CORRESPONDENCE
Jeﬀrey L Schnipper
Division of General Medicine
Brigham and Women’s Hospital
1620 Tremont Street
Boston, MA 02120–1613
USA
Tel: +1 (617) 732 6201
Fax: +1 (617) 732 7072
Email: jschnipper@partners.org
Accepted April 2008

